• Oncobiologics Enters First CDMO Contract contractpharma
    June 19, 2018
    Oncobiologics  has entered into a Master Services Agreement (MSA) with Sonnet BioTherapeutics, a privately held development stage biopharmaceutical company, and has officially launched its BioSymphony Platform-based contract development and manufacturing
PharmaSources Customer Service